Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

enVVeno Medical (NVNO) EBITDA Margin (2017 - 2019)

enVVeno Medical has reported EBITDA Margin over the past 3 years, most recently at 5064.63% for Q1 2019.

  • Quarterly results put EBITDA Margin at 5064.63% for Q1 2019, down 37628.0% from a year ago — trailing twelve months through Dec 2019 was 24566.51% (down 2035600.0% YoY), and the annual figure for FY2020 was 4231.07%, up 2879757.0%.
  • EBITDA Margin for Q1 2019 was 5064.63% at enVVeno Medical, up from 5905.47% in the prior quarter.
  • Over the last five years, EBITDA Margin for NVNO hit a ceiling of 1101.34% in Q4 2017 and a floor of 6499.91% in Q3 2017.
  • Median EBITDA Margin over the past 3 years was 4210.58% (2018), compared with a mean of 4217.23%.
  • Peak annual rise in EBITDA Margin hit 292915bps in 2018, while the deepest fall reached -480413bps in 2018.
  • enVVeno Medical's EBITDA Margin stood at 1101.34% in 2017, then plummeted by -436bps to 5905.47% in 2018, then rose by 14bps to 5064.63% in 2019.
  • The last three reported values for EBITDA Margin were 5064.63% (Q1 2019), 5905.47% (Q4 2018), and 3570.75% (Q3 2018) per Business Quant data.